117 related articles for article (PubMed ID: 24463217)
1. Specific targeting of tumor cells by lyophilisomes functionalized with antibodies.
van Bracht E; Stolle S; Hafmans TG; Boerman OC; Oosterwijk E; van Kuppevelt TH; Daamen WF
Eur J Pharm Biopharm; 2014 May; 87(1):80-9. PubMed ID: 24463217
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
van Bracht E; Versteegden LR; Stolle S; Verdurmen WP; Woestenenk R; Raavé R; Hafmans T; Oosterwijk E; Brock R; van Kuppevelt TH; Daamen WF
PLoS One; 2014; 9(11):e110813. PubMed ID: 25369131
[TBL] [Abstract][Full Text] [Related]
3. Lyophilisomes as a new generation of drug delivery capsules.
van Bracht E; Raavé R; Verdurmen WP; Wismans RG; Geutjes PJ; Brock RE; Oosterwijk E; van Kuppevelt TH; Daamen WF
Int J Pharm; 2012 Dec; 439(1-2):127-35. PubMed ID: 23069914
[TBL] [Abstract][Full Text] [Related]
4. Attachment of an anti-MUC1 monoclonal antibody to 5-FU loaded BSA nanoparticles for active targeting of breast cancer cells.
Kouchakzadeh H; Shojaosadati SA; Mohammadnejad J; Paknejad M; Rasaee MJ
Hum Antibodies; 2012; 21(3-4):49-56. PubMed ID: 23549021
[TBL] [Abstract][Full Text] [Related]
5. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.
Esfandyari-Manesh M; Mohammadi A; Atyabi F; Nabavi SM; Ebrahimi SM; Shahmoradi E; Varnamkhasti BS; Ghahremani MH; Dinarvand R
Int J Pharm; 2016 Dec; 515(1-2):607-615. PubMed ID: 27989825
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution of size-selected lyophilisomes in mice.
van Bracht E; Raavé R; Perevyazko IY; Versteeg EM; Hafmans TG; Schubert US; Oosterwijk E; van Kuppevelt TH; Daamen WF
Eur J Pharm Biopharm; 2015 Aug; 94():141-51. PubMed ID: 25953331
[TBL] [Abstract][Full Text] [Related]
7. A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells.
Cai L; Qiu N; Li X; Luo K; Chen X; Yang L; He G; Wei Y; Chen L
Int J Pharm; 2011 Apr; 408(1-2):173-82. PubMed ID: 21277964
[TBL] [Abstract][Full Text] [Related]
8. Protein corona hampers targeting potential of MUC1 aptamer functionalized SN-38 core-shell nanoparticles.
Varnamkhasti BS; Hosseinzadeh H; Azhdarzadeh M; Vafaei SY; Esfandyari-Manesh M; Mirzaie ZH; Amini M; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2015 Oct; 494(1):430-44. PubMed ID: 26315125
[TBL] [Abstract][Full Text] [Related]
9. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of lipid immuno-nanocapsules for directed drug delivery: selective antitumor activity against HER2 positive breast-cancer cells.
Sánchez-Moreno P; Ortega-Vinuesa JL; Boulaiz H; Marchal JA; Peula-García JM
Biomacromolecules; 2013 Dec; 14(12):4248-59. PubMed ID: 24134122
[TBL] [Abstract][Full Text] [Related]
11. Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes.
van der Steen SC; Raavé R; Langerak S; van Houdt L; van Duijnhoven SM; van Lith SA; Massuger LF; Daamen WF; Leenders WP; van Kuppevelt TH
Eur J Pharm Biopharm; 2017 Apr; 113():229-239. PubMed ID: 28034806
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of a preclinical ovarian carcinoma model to investigate the mechanism of acquired resistance to trastuzumab.
Luistro LL; Rosinski JA; Bian H; Bishayee S; Rameshwar P; Ponzio NM; Ritland SR
Int J Oncol; 2012 Aug; 41(2):639-51. PubMed ID: 22580986
[TBL] [Abstract][Full Text] [Related]
13. Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles.
Wagner S; Rothweiler F; Anhorn MG; Sauer D; Riemann I; Weiss EC; Katsen-Globa A; Michaelis M; Cinatl J; Schwartz D; Kreuter J; von Briesen H; Langer K
Biomaterials; 2010 Mar; 31(8):2388-98. PubMed ID: 20031203
[TBL] [Abstract][Full Text] [Related]
14. Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells.
Taheri A; Dinarvand R; Atyabi F; Ghahremani MH; Ostad SN
Eur J Pharm Sci; 2012 Sep; 47(2):331-40. PubMed ID: 22771547
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation.
Hasegawa M; Sinha RK; Kumar M; Alam M; Yin L; Raina D; Kharbanda A; Panchamoorthy G; Gupta D; Singh H; Kharbanda S; Kufe D
Clin Cancer Res; 2015 May; 21(10):2338-47. PubMed ID: 25712682
[TBL] [Abstract][Full Text] [Related]
17. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells.
Steinhauser I; Spänkuch B; Strebhardt K; Langer K
Biomaterials; 2006 Oct; 27(28):4975-83. PubMed ID: 16757022
[TBL] [Abstract][Full Text] [Related]
18. Clickable protein nanocapsules for targeted delivery of recombinant p53 protein.
Zhao M; Liu Y; Hsieh RS; Wang N; Tai W; Joo KI; Wang P; Gu Z; Tang Y
J Am Chem Soc; 2014 Oct; 136(43):15319-25. PubMed ID: 25289975
[TBL] [Abstract][Full Text] [Related]
19. Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells.
Sadeqzadeh E; Rahbarizadeh F; Ahmadvand D; Rasaee MJ; Parhamifar L; Moghimi SM
J Control Release; 2011 Nov; 156(1):85-91. PubMed ID: 21704663
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells.
Maya S; Kumar LG; Sarmento B; Sanoj Rejinold N; Menon D; Nair SV; Jayakumar R
Carbohydr Polym; 2013 Apr; 93(2):661-9. PubMed ID: 23499109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]